x

Emmaus Life Sciences, Inc. (OTC:EMMA)

Business/Consumer Services • Computer Services
CIK 822370
Company

Emmaus Life Sciences, Inc. operates as a biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.

Address
21250 Hawthorne Boulevard
Suite 800
Torrance, California 90503
Employees
55
Stock Info
Close
$0.1100
Day Range
0.1003 - 0.1305
52 Week Range
0.0506 - 0.4000
Average volume
39.42K
Short Interest
41.22K (08/15/19)
% of Float Shorted
0.16%
Market Cap
$5.9M
Revenue
$18.39M
Net Income
-$10.63M
2020 Sales Growth
N/A
Rev. per Employee
$517.46K
P/E Ratio
N/A
EPS
-$0.0931
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman, Co-President & Chief Operating Officer
Willis C Lee
Co-President, Director & Chief Commercial Officer
George Sekulich
Independent Director
Ian Zwicker MBA
Independent Director
Seah H LIm MD, PhD
Independent Director
Wei Peu Zen MBA
SEC filings
DateFormEvent
19 Nov, 2024 8-K
19 Nov, 2024 10-Q
14 Nov, 2024 NT 10-Q
6 Nov, 2024 8-K
25 Oct, 2024 8-K
9 Oct, 2024 3
4 Oct, 2024 8-K
18 Sep, 2024 4
10 Sep, 2024 10-Q
10 Sep, 2024 8-K
10 Sep, 2024 10-Q
15 Aug, 2024 NT 10-Q
17 Jul, 2024 8-K
3 Jul, 2024 10-K
3 Jul, 2024 8-K
28 May, 2024 8-K
1 Apr, 2024 NT 10-K
29 Feb, 2024 4
26 Feb, 2024 8-K
5 Feb, 2024 4
5 Feb, 2024 4
5 Feb, 2024 4
5 Feb, 2024 4
5 Feb, 2024 4
5 Feb, 2024 4
5 Feb, 2024 4
3 Jan, 2024 4/A
22 Dec, 2023 SC 13G
21 Dec, 2023 4
20 Dec, 2023 8-K
20 Dec, 2023 3/A
19 Dec, 2023 4
19 Dec, 2023 4
4 Dec, 2023 4
14 Nov, 2023 8-K
14 Nov, 2023 10-Q
4 Oct, 2023 8-K CEO Change
23 Aug, 2023 8-K
14 Aug, 2023 10-Q
14 Aug, 2023 8-K
2 Jun, 2023 4
15 May, 2023 8-K
15 May, 2023 10-Q
31 Mar, 2023 8-K
31 Mar, 2023 10-K
7 Mar, 2023 8-K
21 Feb, 2023 SC 13D/A
31 Jan, 2023 D
20 Jan, 2023 D
20 Jan, 2023 4
19 Jan, 2023 8-K
19 Jan, 2023 4/A
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
12 Dec, 2022 8-K
1 Dec, 2022 4
15 Nov, 2022 8-K
14 Nov, 2022 10-Q
9 Nov, 2022 SC 13D/A
3 Nov, 2022 4
31 Oct, 2022 4
31 Oct, 2022 DEF 14A
24 Oct, 2022 4
21 Oct, 2022 PRE 14A
19 Oct, 2022 4
17 Oct, 2022 4
13 Oct, 2022 4
12 Oct, 2022 4
6 Oct, 2022 3
6 Oct, 2022 8-K
6 Oct, 2022 3
30 Sep, 2022 8-K
19 Aug, 2022 8-K
15 Aug, 2022 8-K
15 Aug, 2022 10-Q
10 Aug, 2022 8-K
25 Jul, 2022 4
1 Jul, 2022 10-K/A
30 Jun, 2022 D
10 Jun, 2022 8-K CEO Change
3 Jun, 2022 4
2 Jun, 2022 4
19 May, 2022 4
13 May, 2022 10-Q
13 May, 2022 8-K
12 Apr, 2022 4
31 Mar, 2022 8-K
31 Mar, 2022 10-K
2 Mar, 2022 4
28 Feb, 2022 4
28 Feb, 2022 4
23 Feb, 2022 4
18 Feb, 2022 4
17 Feb, 2022 SC 13D/A
16 Feb, 2022 4
11 Feb, 2022 4
9 Feb, 2022 4
7 Feb, 2022 4
24 Jan, 2022 3
10 Jan, 2022 8-K
5 Jan, 2022 4
5 Jan, 2022 4
3 Jan, 2022 4
30 Dec, 2021 S-8
28 Dec, 2021 4
28 Dec, 2021 3
22 Dec, 2021 4
20 Dec, 2021 3
17 Dec, 2021 4
10 Dec, 2021 4
6 Dec, 2021 4
2 Dec, 2021 4
1 Dec, 2021 SC 13D/A
30 Nov, 2021 4
30 Nov, 2021 3
30 Nov, 2021 4
29 Nov, 2021 8-K
26 Nov, 2021 4
26 Nov, 2021 4
23 Nov, 2021 4
23 Nov, 2021 4
19 Nov, 2021 4
12 Nov, 2021 10-Q
22 Oct, 2021 4
12 Oct, 2021 DEF 14A
12 Oct, 2021 8-K
7 Oct, 2021 4
30 Sep, 2021 PRE 14A
29 Sep, 2021 4
27 Sep, 2021 4
23 Sep, 2021 4
17 Sep, 2021 4
17 Sep, 2021 4
13 Sep, 2021 4
10 Sep, 2021 4
8 Sep, 2021 4
2 Sep, 2021 4
1 Sep, 2021 10-Q
1 Sep, 2021 10-Q
27 Aug, 2021 4
26 Aug, 2021 4
26 Aug, 2021 10-Q
26 Aug, 2021 10-Q
26 Aug, 2021 10-Q
23 Aug, 2021 4
18 Aug, 2021 4
13 Aug, 2021 4
10 Aug, 2021 8-K
10 Aug, 2021 4
10 Aug, 2021 10-K/A
5 Aug, 2021 4
2 Aug, 2021 4
28 Jul, 2021 4
23 Jul, 2021 4
22 Jul, 2021 SC 13D/A
20 Jul, 2021 4
15 Jul, 2021 4
12 Jul, 2021 4
7 Jul, 2021 4
1 Jul, 2021 4
28 Jun, 2021 4
22 Jun, 2021 4
17 Jun, 2021 4
14 Jun, 2021 4
9 Jun, 2021 4
3 Jun, 2021 4
28 May, 2021 4
28 May, 2021 4
25 May, 2021 4
20 May, 2021 4
19 May, 2021 8-K
17 May, 2021 NT 10-Q
14 May, 2021 4
12 May, 2021 4
10 May, 2021 4
7 May, 2021 4
4 May, 2021 10-K
31 Mar, 2021 NT 10-K
22 Feb, 2021 8-K
16 Feb, 2021 8-K
16 Feb, 2021 D
25 Jan, 2021 10-K
Last update:2024-03-06 12:53:54.997291
Emmaus Life Sciences, Inc. by TradingView

Sign Up to Subscribe